Diarrhea-predominant irritable bowel syndrome
Conditions
Interventions
Control group:Acupuncture at non-specific acupoints and electroacupuncture is not electrified
Observation group:Acupuncture at Tianshu Zusanli and Taichong acupoints and electroacupuncture is energized.
Sponsors
Chengdu University of Traditional Chinese Medicine Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Meets the diagnostic criteria of Rome IV diarrheal irritable bowel syndrome subtype; (2) Age 18-75 years old male or female; (3) Daily defecation diary reporting Bristol fecal trait type 6 or 7 for at least 4 days and Bristol fecal trait type 1 or 2 for less than 4 days in the last 2 weeks; (4) Have not received acupuncture treatment in the past 6 months; (5) Have not used any medication for IBS-D at least 2 weeks before entering treatment; (6) Sign informed consent and participate in this study voluntarily. Note: Patients who meet the above 6 criteria can be included in this study.
Exclusion criteria
Exclusion criteria: (1) Constipated IBS/ mixed IBS and confirmed presence of other organic gastrointestinal diseases (such as inflammatory bowel disease intestinal tuberculosis microscopic colitis history of celiac disease Crohn's disease intestinal tumors etc.); (2) Systemic diseases affecting digestive tract dynamics (such as hyperthyroidism diabetes chronic renal insufficiency etc.); (3) Complicated with serious diseases (such as malignant tumors serious cardiovascular respiratory liver kidney nervous system diseases etc.); (4) Warning signs such as unexplained anemia blood in the stool significant weight loss abdominal mass ascites fever a family history of colorectal cancer or inflammatory bowel disease; (5) Patients with abdominal surgery that may have caused symptoms similar to IBS (patients with appendix surgery hemorrhoid surgery and polyp surgery over 3 months can be included); (6) During pregnancy or lactation; (7) Suspected or have a history of alcohol and drug abuse; (8) Those who have serious mental illness serious mental illness obvious impairment of cognitive function or can not conduct questionnaire due to educational level; (9) Patients who are participating in other clinical trials; (10) Other situations that the researcher considers unsuitable for this study. Note: Patients who meet any 1 of the above criteria will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IBS symptom severity scale(IBS-SSS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Adequate relief of symptoms of irritable bowel syndrome (IBS-AR);Irritable Bowel Syndrome Quality of Life (IBS-QOL);Pittsburgh sleep quality index (PSQI);Self-Rating Anxiety Scale (SAS);Self-Rating Depression Scale (SDS); | — |
Countries
China
Contacts
Public ContactSiyuan Zhou
Chengdu University of Traditional Chinese Medicine
Outcome results
None listed